Sign In
Buy UHS
$142.87
-2.30 (-1.58%)
At Close: Jun 08, 2026
Is Universal Health Services Stock a Bargain Following Hospital Closure?
06:45am, Thursday, 23'rd Mar 2023
Closing down the 282-bed Desert Springs Hospital in Las Vegas hit UHS with a $57.6 million one-time charge. The end of government COVID-19 reimbursements also affected the bottom line.
Universal Health (UHS) Up 26% in 6 Months: More Room to Run?
04:03pm, Monday, 20'th Mar 2023
Universal Health (UHS) is well-poised for growth on the back of improved patient volumes, acquisitions and robust cash-generating abilities.
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT CITI'S 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE
04:15pm, Wednesday, 01'st Mar 2023
KING OF PRUSSIA, Pa. , March 1, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participa
Universal Health (UHS) Q4 Earnings Beat on Solid Segments
01:33pm, Tuesday, 28'th Feb 2023
Universal Health's (UHS) fourth-quarter results indicate growing revenues in its segments resulting from higher patient volumes. Management expects adjusted EPS within $9.50-$10.50 for 2023.
Universal Health Services (UHS) Tops Q4 Earnings and Revenue Estimates
06:49pm, Monday, 27'th Feb 2023
Universal Health Services (UHS) delivered earnings and revenue surprises of 2.03% and 1.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto
Universal Health Services 2023 sales forecast, fourth-quarter results beat expectations
04:54pm, Monday, 27'th Feb 2023
Universal Health Services Inc. UHS, -0.60% on Monday forecast full-year sales that were above analysts' expectations, but profits that came up short. The company — whose facilities provide mental-
Universal Health (UHS) to Post Q4 Earnings: What to Expect
12:48pm, Wednesday, 22'nd Feb 2023
Universal Health's (UHS) fourth-quarter results are likely to reflect an increase in same facility adjusted admissions in acute care hospitals.
Universal Health: Retain Buy As Systematic Defensive Overlay
08:54am, Saturday, 04'th Feb 2023
Universal Health Services continues to present as an attractive name as part of a systematic defensive overlay for equity portfolios. Despite a tight year in post-tax earnings, UHS still represents va
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR 2022 FOURTH QUARTER AND FULL YEAR EARNINGS RELEASE AND CONFERENCE CALL
05:40pm, Wednesday, 01'st Feb 2023
KING OF PRUSSIA, Pa., Feb. 1, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its fourth quarter and full year ended December 31, 2022
5 Best and Worst Performing Health Care Stocks in December 2022
10:51pm, Monday, 23'rd Jan 2023
Despite inflation making it hard for the healthcare industry to manage its operating costs, there are a few positives that make this sector attractive to investors.
Investors Should Watch These 4 Hospital Stocks Despite Headwinds
09:47am, Tuesday, 17'th Jan 2023
Rising costs amid inflationary pressures are trimming margins for the Zacks Medical-Hospital industry players. Yet, HCA Healthcare (HCA), Universal Health (UHS), Acadia Healthcare (ACHC) and Tenet Hea
These Were the 5 Best and Worst Performing Large-Cap Stocks in Q4 2022
10:55pm, Friday, 06'th Jan 2023
The year 2022 proved to be the worst calendar year for the S&P 500 since 2008.
Should You Buy Universal Health Services Stock At $133?
08:45am, Tuesday, 29'th Nov 2022
Universal Health Services stock (NYSE: UHS), a hospital and healthcare services provider, has seen a 2% rise this year, outperforming the broader S&P500 index, down 16%.
Universal Health Services (UHS) Up 18.5% Since Last Earnings Report: Can It Continue?
12:47pm, Thursday, 24'th Nov 2022
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock?
Universal Health Services: Attractive Even In Light Of Cost Concerns
01:14pm, Monday, 14'th Nov 2022
Universal Health Services continues to grow its topline nicely, but bottom line results have been discouraging this year. This is problematic, but this doesn't mean the company isn't worth considering
